Waddell & Associates’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,111
Closed -$562K 171
2023
Q3
$562K Hold
1,111
0.08% 73
2023
Q2
$579K Buy
1,111
+16
+1% +$8.63K 0.09% 68
2023
Q1
$631K Buy
1,095
+1
+0.1% +$564 0.1% 65
2022
Q4
$603K Buy
1,094
+11
+1% +$5.83K 0.1% 67
2022
Q3
$549K Buy
1,083
+1
+0.1% +$560 0.11% 61
2022
Q2
$588K Buy
+1,082
New +$596K 0.12% 61
2021
Q3
Sell
-1,076
Closed -$543K 131
2021
Q2
$543K Buy
+1,076
New +$508K 0.08% 57

Other funds holding TMO

Waddell & Associates's TMO Position: Q4 2023 in Review

Waddell & Associates sold out of Thermo Fisher Scientific (TMO) in Q4 2023, closing a stake of 1,111 shares — an estimated $562K sold.

Waddell & Associates first reported a position in TMO in Q2 2021 and held it in 7 quarters. The position peaked at $631K in Q1 2023. 2,491 funds tracked by Wall St. Rank hold TMO as of Q4 2023.

  • Waddell & Associates reported no remaining Thermo Fisher Scientific position as of Q4 2023 after selling out during the quarter.
  • Waddell & Associates sold 1,111 Thermo Fisher Scientific shares in Q4 2023, an estimated $562K.
  • Waddell & Associates first reported a position in Thermo Fisher Scientific in Q2 2021 and held it in 7 quarters.
  • Waddell & Associates's Thermo Fisher Scientific position peaked at $631K in Q1 2023.
  • 2,491 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2023.

Based on Waddell & Associates's 13F filing for Q4 2023, filed 14 Feb 2024.